技术引导的透析患者干重调整的有效性和安全性:随机对照试验的荟萃分析。

IF 3.4 Q1 UROLOGY & NEPHROLOGY
Kidney Medicine Pub Date : 2025-06-17 eCollection Date: 2025-08-01 DOI:10.1016/j.xkme.2025.101052
Wannasit Wathanavasin, Charat Thongprayoon, Paul W Davis, Wisit Cheungpasitporn
{"title":"技术引导的透析患者干重调整的有效性和安全性:随机对照试验的荟萃分析。","authors":"Wannasit Wathanavasin, Charat Thongprayoon, Paul W Davis, Wisit Cheungpasitporn","doi":"10.1016/j.xkme.2025.101052","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale & objective: </strong>Recently, various instrumental techniques adjunct to standard clinical evaluation have been used to improve fluid balance and guide dry weight adjustments in dialysis populations. We aimed to explore the efficacy and safety of using technology-guided dry weight adjustment among dialysis patients.</p><p><strong>Study design: </strong>Systematic review and meta-analysis of randomized controlled trials (RCTs). The search was conducted in PubMed, Scopus, and Cochrane Central Register of Controlled Trials for relevant RCTs published until April 28, 2024.</p><p><strong>Setting & participants: </strong>Adult patients with kidney failure with replacement therapy.</p><p><strong>Exposure: </strong>Studies with patients receiving technology-guided dry weight adjustments.</p><p><strong>Outcomes: </strong>Studies were selected if they reported at least 1 outcome of interest (eg, mortality, cardiovascular [CV] events, hospitalization, intradialytic hypotension, hypovolemic events, cardiac arrhythmia, or vascular access problems).</p><p><strong>Analytical approach: </strong>Random-effects meta-analyses were conducted, with risk of bias within studies assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials.</p><p><strong>Results: </strong>A total of 21 RCTs involving 4,239 dialysis patients were analyzed. The meta-analysis revealed that the incorporating technology-guided dry weight adjustment not only was associated with a significant 21% reduction in CV events (relative risk, 0.79; 95% confidence interval [CI], 0.71-0.88) but also resulted in a significant 9% increase in muscle cramps (rate ratio, 1.09; 95% CI, 1.02-1.16). In a subgroup analysis, using bioelectrical impedance analysis was associated with a significant reduction in mortality (relative risk, 0.67; 95% CI, 0.51-0.89). In addition, the intervention led to a significant reduction in pulse wave velocity (mean difference, -2.43 m/s; 95% CI, -4.64 to -0.21).</p><p><strong>Limitations: </strong>Large number of studies with some concerns or a high risk of bias.</p><p><strong>Conclusions: </strong>Technology-guided strategies for dry weight adjustment significantly reduce CV events and may lower all-cause mortality in dialysis patients. These benefits are particularly evident with bioelectrical impedance analysis--guided interventions. Nonetheless, clinicians should be aware of a modestly increased risk of muscle cramps.</p>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 8","pages":"101052"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309956/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Efficacy and Safety of Technology-Guided Dry Weight Adjustment Among Dialysis Patients: A Meta-analysis of Randomized Controlled Trials.\",\"authors\":\"Wannasit Wathanavasin, Charat Thongprayoon, Paul W Davis, Wisit Cheungpasitporn\",\"doi\":\"10.1016/j.xkme.2025.101052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale & objective: </strong>Recently, various instrumental techniques adjunct to standard clinical evaluation have been used to improve fluid balance and guide dry weight adjustments in dialysis populations. We aimed to explore the efficacy and safety of using technology-guided dry weight adjustment among dialysis patients.</p><p><strong>Study design: </strong>Systematic review and meta-analysis of randomized controlled trials (RCTs). The search was conducted in PubMed, Scopus, and Cochrane Central Register of Controlled Trials for relevant RCTs published until April 28, 2024.</p><p><strong>Setting & participants: </strong>Adult patients with kidney failure with replacement therapy.</p><p><strong>Exposure: </strong>Studies with patients receiving technology-guided dry weight adjustments.</p><p><strong>Outcomes: </strong>Studies were selected if they reported at least 1 outcome of interest (eg, mortality, cardiovascular [CV] events, hospitalization, intradialytic hypotension, hypovolemic events, cardiac arrhythmia, or vascular access problems).</p><p><strong>Analytical approach: </strong>Random-effects meta-analyses were conducted, with risk of bias within studies assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials.</p><p><strong>Results: </strong>A total of 21 RCTs involving 4,239 dialysis patients were analyzed. The meta-analysis revealed that the incorporating technology-guided dry weight adjustment not only was associated with a significant 21% reduction in CV events (relative risk, 0.79; 95% confidence interval [CI], 0.71-0.88) but also resulted in a significant 9% increase in muscle cramps (rate ratio, 1.09; 95% CI, 1.02-1.16). In a subgroup analysis, using bioelectrical impedance analysis was associated with a significant reduction in mortality (relative risk, 0.67; 95% CI, 0.51-0.89). In addition, the intervention led to a significant reduction in pulse wave velocity (mean difference, -2.43 m/s; 95% CI, -4.64 to -0.21).</p><p><strong>Limitations: </strong>Large number of studies with some concerns or a high risk of bias.</p><p><strong>Conclusions: </strong>Technology-guided strategies for dry weight adjustment significantly reduce CV events and may lower all-cause mortality in dialysis patients. These benefits are particularly evident with bioelectrical impedance analysis--guided interventions. Nonetheless, clinicians should be aware of a modestly increased risk of muscle cramps.</p>\",\"PeriodicalId\":17885,\"journal\":{\"name\":\"Kidney Medicine\",\"volume\":\"7 8\",\"pages\":\"101052\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-06-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309956/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.xkme.2025.101052\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xkme.2025.101052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

理由与目的:最近,各种辅助标准临床评估的仪器技术已被用于改善透析人群的体液平衡和指导干体重调整。我们的目的是探讨在透析患者中使用技术引导的干体重调整的有效性和安全性。研究设计:随机对照试验(rct)的系统评价和荟萃分析。在PubMed、Scopus和Cochrane Central Register of Controlled Trials中检索截至2024年4月28日发表的相关随机对照试验。环境和参与者:接受替代治疗的成年肾衰竭患者。暴露:接受技术引导的干体重调整的患者的研究。结局:如果研究报告了至少1个相关结局(如死亡率、心血管事件、住院、分析性低血压、低血容量事件、心律失常或血管通路问题),则选择研究。分析方法:进行随机效应荟萃分析,使用Cochrane随机试验风险偏倚工具第2版评估研究中的偏倚风险。结果:共分析了21项随机对照试验,涉及4239例透析患者。荟萃分析显示,结合技术指导的干体重调整不仅与显著降低21%的CV事件相关(相对风险,0.79;95%可信区间[CI], 0.71-0.88),但也导致肌肉痉挛显著增加9%(比率比,1.09;95% ci, 1.02-1.16)。在亚组分析中,使用生物电阻抗分析与死亡率显著降低相关(相对危险度,0.67;95% ci, 0.51-0.89)。此外,干预导致脉冲波速度显著降低(平均差为-2.43 m/s;95% CI, -4.64 ~ -0.21)。局限性:大量的研究存在一些问题或高偏倚风险。结论:技术指导下的干重调整策略可显著减少心血管事件,并可能降低透析患者的全因死亡率。这些好处在生物电阻抗分析指导的干预措施中尤为明显。尽管如此,临床医生应该意识到肌肉痉挛的风险适度增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Efficacy and Safety of Technology-Guided Dry Weight Adjustment Among Dialysis Patients: A Meta-analysis of Randomized Controlled Trials.

Rationale & objective: Recently, various instrumental techniques adjunct to standard clinical evaluation have been used to improve fluid balance and guide dry weight adjustments in dialysis populations. We aimed to explore the efficacy and safety of using technology-guided dry weight adjustment among dialysis patients.

Study design: Systematic review and meta-analysis of randomized controlled trials (RCTs). The search was conducted in PubMed, Scopus, and Cochrane Central Register of Controlled Trials for relevant RCTs published until April 28, 2024.

Setting & participants: Adult patients with kidney failure with replacement therapy.

Exposure: Studies with patients receiving technology-guided dry weight adjustments.

Outcomes: Studies were selected if they reported at least 1 outcome of interest (eg, mortality, cardiovascular [CV] events, hospitalization, intradialytic hypotension, hypovolemic events, cardiac arrhythmia, or vascular access problems).

Analytical approach: Random-effects meta-analyses were conducted, with risk of bias within studies assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials.

Results: A total of 21 RCTs involving 4,239 dialysis patients were analyzed. The meta-analysis revealed that the incorporating technology-guided dry weight adjustment not only was associated with a significant 21% reduction in CV events (relative risk, 0.79; 95% confidence interval [CI], 0.71-0.88) but also resulted in a significant 9% increase in muscle cramps (rate ratio, 1.09; 95% CI, 1.02-1.16). In a subgroup analysis, using bioelectrical impedance analysis was associated with a significant reduction in mortality (relative risk, 0.67; 95% CI, 0.51-0.89). In addition, the intervention led to a significant reduction in pulse wave velocity (mean difference, -2.43 m/s; 95% CI, -4.64 to -0.21).

Limitations: Large number of studies with some concerns or a high risk of bias.

Conclusions: Technology-guided strategies for dry weight adjustment significantly reduce CV events and may lower all-cause mortality in dialysis patients. These benefits are particularly evident with bioelectrical impedance analysis--guided interventions. Nonetheless, clinicians should be aware of a modestly increased risk of muscle cramps.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信